SXSW 2014 and the Outcomes of the Future - Bill Drummy, CEO & Founder, Heartbeat Ideas & Heartbeat West

Page created by Rafael Clark
 
CONTINUE READING
SXSW 2014 and the Outcomes of the Future - Bill Drummy, CEO & Founder, Heartbeat Ideas & Heartbeat West
SXSW 2014
and the Outcomes of the Future

Bill Drummy, CEO & Founder, Heartbeat Ideas & Heartbeat West

                 As published by PharmExec.com, March 2014

                                                               heartbeatideas.com
                                                               heartbeatwest.com
SXSW 2014 and the Outcomes of the Future - Bill Drummy, CEO & Founder, Heartbeat Ideas & Heartbeat West
SXSW 2014 and the Outcomes of the Future

  I’m just back from South by Southwest (SXSW) Interactive, the trendy, geeky, culture-fest that
  has grown enormously influential for the technology industry. It may come as some surprise, but
  SXSW Interactive has now become arguably the hottest healthcare conference in the country.

      “We’ve been doing health-related programming for the last several years,
       but 2014 is the first year that we have featured the programming so prominently,”
                                 - Hugh Forrest, the director of South by Southwest Interactive, as told to the Wall Street Journal

  I never got an exact number, but it seemed to me that one in three sessions was devoted to
  healthcare in one sense or another; everything from “Doctors on their Deathbeds” to “Is there a
  Neurological Recipe for Success?” to “Inventing Tumor Paint: Tapping Into Nature’s DNA” and
  all the way to “Tech off your Clothes: Naked Truths of Wearables”, which (naturally) featured
  lingerie models on stage.

  Yet although the substance of some topics appeared scandalously thin, the most enveloping
  theme (and indeed the gestalt) of the entire conference concerned the serious topic of privacy.
  We had a Google+ video feed of Julian Assange (from an embassy in London) and Edward
  Snowden (from somewhere in Moscow) who both railed about the value of personal privacy
  and the threat of government intrusion. (Snowden appeared, apparently without irony, before
  an image of the US Constitution, from inside Putin’s Russia and from behind what looks to be a
  rapidly reconstituting Iron Curtain.)

  heartbeatideas.com | heartbeatwest.com                                                                                              2
SXSW 2014 and the Outcomes of the Future - Bill Drummy, CEO & Founder, Heartbeat Ideas & Heartbeat West
SXSW 2014 and the Outcomes of the Future

  Why You Should Care
  OK, so politically divisive and culturally au courant—granted. But you’re wondering, what do you
  learn in a few days in Austin that’s so important to me and my business?

  It simmers down to three things:

   1. The topsy-like spread of wearable technologies—with their accompanying oceans of data about
      human behavior and healthcare decision-making—is rapidly opening up new pathways for
      clinical discovery, improved patient management and superior outcomes.

   2. The Privacy discussion itself teased out a fascinating possible resolution to the apparently
      inescapable conflict between personal security and open sharing of health information.

   3. The emergence of technology companies into the healthcare space represents either an
      enormous threat or a scintillating opportunity for pharma… most likely both.

  Data, Data, Everywhere, and All the Bands Did Shriek
  The     single     topic     most        at   risk   of
  overexposure at SXSW was certainly
  wearable devices for healthcare (or,
  as I like to call them, “Healthwear”).
  Between        sessions,       meet-ups,         book
  signings and pitch events, Healthwear
  was everywhere and covering everything.
  In fact, one speaker, Rachel Kalmar from
  Misfit Wearables, was draped in more
  than 30 devices.

  heartbeatideas.com | heartbeatwest.com                                                             3
SXSW 2014 and the Outcomes of the Future - Bill Drummy, CEO & Founder, Heartbeat Ideas & Heartbeat West
SXSW 2014 and the Outcomes of the Future

  But it looks like Healthwear has moved beyond the “fad”
  stage: according to Canalys, 1.8 million bands were sold in
  2013, and some 8 million will ship in 2014, and shipments
  will reach 45 million in 2017.

  A burgeoning consumer trend perhaps. But the real
  story and the real power of all these devices lies in
  what can be done with all the data they transmit.
  According to Monica Rogati, VP of Data at Jawbone,
  the company behind the “UP” band, they are now
  collecting data about the sleep patterns of 50 million
  nights of sleep. “And that shows us patterns you just
  can’t see without using a dataset that large,” she said.

  You can imagine the potential of providing this kind
  of large-scale analytics to a wide variety of healthcare
  conditions: CNS, cardiovascular, diabetes and other
  metabolic disorders—the list is long.         And broad.
  The data from current and future devices may help in
  recruiting candidates for clinical trials, identifying
  the best genetic types for certain targeted therapies,
  and improving outcomes because of the proven link
  between behavior tracking and behavior change.

  To me, this represents the most exciting potential for Healthwear—its capability as a tool to
  help people get healthier, stay healthier and recover faster from illness or injury. But there was a
  heated debate at SXSW about how much of this enthusiasm was warranted by the data, and how
  much was “fanboy” hyperbole promulgated by techy Pollyannas.

  I will admit to my own fanboy tendencies, but I will also note that Aetna’s CarePass Service is now
  working with FitBit to measure whether customers wearing the devices (and tracking consistently)
  actually see improved health outcomes. According to Tim Roberts, VP, Interactive & Design at
  FitBit, incorporating devices has allowed some employers to reduce costs by up to 4%.

  heartbeatideas.com | heartbeatwest.com                                                             4
SXSW 2014 and the Outcomes of the Future - Bill Drummy, CEO & Founder, Heartbeat Ideas & Heartbeat West
SXSW 2014 and the Outcomes of the Future

  Private Lives and Public Goods
  But making real the dream of better health
  through better tracking rests on a particularly
  pointy fulcrum: the tenuous balance between
  personal privacy and open sharing of data.

  As the Assange and Snowden keynotes made
  clear, privacy was in the air in Austin.

  I tweeted actively in virtually all the sessions I
  attended, because this is the way I take notes.
  I posted 350+ tweets over three days and, as it
  works in the Twitterverse, your best gauge that
  something you tweeted was interesting is the number of people who retweeted the post. To my
  surprise, my most retweeted post was not the Tweetpic from the “Tech Your Clothes Off” panel
  (the one with the lingerie models). Rather, it was this:

  I was capturing a comment from John Wilbanks in the “My Sensors. My Data?” session.
  Wilbanks, who is Chief Commons Officer for Sage Biometrics, said a lot of very smart things
  about the impact of the “Internet of Everything” on our culture and economy. But the fact that
  designers were, in effect, using their talents for a malicious purpose struck me, and others, as
  particularly chilling. The alternative approach, put forth in session after session, is a kind of
  “radical transparency” where the sharing of data is not hidden but rather completely open and
  even celebrated.

  heartbeatideas.com | heartbeatwest.com                                                          5
SXSW 2014 and the Outcomes of the Future

  For sensors to work most powerfully in healthcare, the implication is that their data will cross-
  pollinate with Electronic Medical Records, insurance profiles and the like. But for that to
  happen, there must be a solve for the privacy vs. openness riddle.

  Later in the day, I thought I heard one. (The coolest thing about attending SXSW is the way
  conversations seem to float and circle back upon themselves, providing meta-commentary on a
  larger theme. Well, at least that’s the intellectually coolest thing.)

  At a session labeled (with obscene hubris) “Computing the Future: MIT Scientists Tell All,”
  Andrew Lo, a finance professor at MIT’s Sloan School of Management, applied a mathematical
  approach to the problem. Apparently, it’s not so novel among mathematicians, but this approach
  hasn’t been used yet in the privacy arena. It’s tantalizingly simple: imagine a piece of data that an
  individual doesn’t want to make public, but upon which some useful group calculations can be made.

  Say the information is salary data. The first person takes his salary and adds a random number,
  the next person does the same, and so on. Once all the numbers have been gathered, each
  participant then subtracts the random number she added initially, and all the other participants
  do the same. The net number represents the sum of all the salary information, so the average
  salary can be easily obtained; yet no one has revealed his personal salary. “Using secure multi-
  party computation... transparency and privacy can both be achieved,” summed up Professor Lo.

  Implementing a more elaborate version of secure multi-party computation offers the promise
  of allowing patient health data to be pooled, without any individual patient’s information being
  revealed. A simple yet powerful solution.

  “In Five Years, Will Pharma Companies Even Exist?”
  A few weeks before SXSW, I traveled to Europe for some speaking engagements. And while
  I was there, I ran into a gentleman from a fast-growing Asian country who worked for a global
  pharmaceutical company. This gentleman was young, bright and ambitious. Yet he saw his
  future not at the global pharma company where he held a prominent position, but more likely at
  a large global technology company where he thought the future of healthcare had a better chance
  of being invented.

  heartbeatideas.com | heartbeatwest.com                                                               6
SXSW 2014 and the Outcomes of the Future

  When I got to SXSW in Texas, where healthcare sessions included many speakers from
  technology companies, and only a small handful from pharma (and seemingly only a
  slightly larger handful of pharma folks in attendance—what’s up with that?), more than one
  commentator privately questioned whether pharma companies would survive the decade: “They
  are just so slow, so fearful and so regulated, I don’t think they can move fast enough to put their
  true advantages to work.”

  And if I were a senior leader at a pharma company hearing that quote, I may react with either a
  dismissive chortle or a shiver of fear. The first reaction is more consoling, but the second may
  actually help to get a better result.

  Because if it’s true that the pharma industry’s erstwhile titans are in jeopardy, surely the shock of
  recognizing the threat represents the best hope for early diagnosis and curative treatment.

  What ails pharma right now, at its root, is a lack of innovation. Lack of novel compounds from the
  labs, lack of new value propositions in a healthcare ecosystem that is rapidly transforming, lack of a
  full-on commitment to superior patient outcomes as the ultimate product we are producing.

  Ultimately, then, the value of the comingling of ideas at SXSW for pharma is the lesson of redefinition.

  Pharma industry leaders must redefine the business to be only about outcomes and measuring
  them; this must define what the company ought to be developing and marketing, whether or not
  it comes in a pill or a syringe.

  Does the industry have sufficient clarity, energy and nerve to make the kinds of decisions they
  need to make to reinvent themselves as the future of healthcare proceeds around them?

  It’s a daunting challenge, certainly, but there are inspiring precedents for companies re-
  inventing themselves to prosper in a new economic context. The most prominent example is
  IBM, which, in the course of its 103 year history, has re-invented itself no fewer than four times,
  most recently in the 1990s when it shifted dramatically from a hardware-centric company to its
  current business model focused on software and consulting services.

  heartbeatideas.com | heartbeatwest.com                                                                 7
SXSW 2014 and the Outcomes of the Future

                                           A little nearer to home in the healthcare space,
                                           major US health insurance companies like Aetna
                                           (very prominent at SXSW) and Humana are right
                                           now assertively redefining their roles in the
                                           ecosystem, seeking to transform how Americans
                                           perceive their fundamental value. From controlling
                                           costs to the system (and thereby, as a nasty side
                                           effect,   compromising      healthcare   quality)   to
                                           improving their customers’ overall quality of
                                           healthcare, and thus outcomes (!), and (only) then
                                           costs to the system.

                                           Maybe what we will see at SXSW 2020 is a world
                                           populated by tech companies with a huge focus on
                                           improving health, insurance companies that have
                                           recreated themselves as humane and efficient care
                                           delivery networks, biotechs that rapidly evolve a
                                           new compound and then move on to the next.

                                           And maybe even a few pharma companies that have
                                           committed themselves to turning the opportunities
                                           of data, technology and an outcomes-centric value
                                           proposition into the industry of the future.

                                           I’d love to be in that session.

  heartbeatideas.com | heartbeatwest.com                                                        8
SXSW 2014 and the Outcomes of the Future

  About the Author
  Bill Drummy is the Founder and CEO of Heartbeat Ideas and
  Heartbeat West, privately held, full service, natively digital agencies
  committed to delivering unconfined marketing innovation in the
  confined environment of healthcare communications.  Celebrating
  its 15th anniversary in 2013, Heartbeat has been proud to call clients
  some of the most well-known organizations in the world, including
  Amgen, Galderma, Memorial Sloan-Kettering Cancer Center, Pfizer,
  Sanofi, and UNICEF.

  A member of the DTC Hall of Fame and the Editorial Advisory
                                                                            Download Contact Card
  Board for Pharmaceutical Executive magazine, Bill is a frequent
                                                                            LinkedIn Profile
  and outspoken industry commentator.  He has been named one of
  the 100 Most Inspiring People by PharmaVOICE magazine and his             Twitter Feed

  Heartbeat partners can hardly believe it.

  Bill drummy
  Founder & CEO
  billd@heartbeatideas.com
  T 212.812.2233

  heartbeatideas.com | heartbeatwest.com                                                            9
SXSW 2014 and the Outcomes of the Future

  About Heartbeat Ideas & Heartbeat West
  Heartbeat Ideas delivers unconfined marketing innovation in the confined environment of
  healthcare communications. A natively digital, full service agency, Heartbeat Ideas has been proud
  to call some of the most well-known companies in the world clients, including Amgen, Galderma,
  Memorial Sloan-Kettering Cancer Center, Pfizer, Sanofi, and UNICEF.

  California-based sister agency, Heartbeat West, brings a spirit of innovation and world-class
  strategic and creative skills to healthcare clients on the West Coast. Managed by sun-seeking
  refugees from Heartbeat Ideas’ New York base, Heartbeat West offers clients the energy and
  uncompromising attitude of a “New York agency,” only with palm trees and better Mexican food.

  Heartbeat Ideas and Heartbeat West are now members of the Publicis Healthcare
  Communications Group.

  Heartbeat Ideas                                         Heartbeat West
  200 Hudson Street, 9th Floor, New York, NY 10013        1207 4th Street, Suite 200, Santa Monica, CA 90401
  T: 212.812.2233                                         T: 310.393.6100
  www.heartbeatideas.com                                  www.heartbeatwest.com

  Interested in keeping up with Heartbeat? Follow us on Twitter, www.twitter.com/heartbeatideas,
  or join us on Facebook at www.facebook.com/heartbeatideas.

  For more information about Heartbeat Ideas and Heartbeat West, contact Jared Watson at
  jaredw@heartbeatideas.com.

  heartbeatideas.com | heartbeatwest.com                                                                       10
You can also read